Question: is this a 2) strong advice, 1) weak advice 0) no advice?

The efficacy and safety of everolimus plus trastuzumab and paclitaxel as first-line treatment for HER2+ advanced breast cancer in the Asian  subset was consistent with that reported previously in the overall population.
user
This is no advice
assistant